EICHORCondition: Hypertrophic Cardiomyopathy · Sponsor: Edgewise Therapeutics, Inc.
This study is being conducted in order to understand the safety and effects of different doses of EDG-7500 as a single dose in adults with obstructive hypertrophic cardiomyopathy (oHCM) and as multiple doses in adults with obstructive or nonobstructive hypertrophic cardiomyopathy (nHCM).
This description comes directly from the study's public registry record.
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
| University of California, San Francisco | San Francisco, California, United States | — |
| Stanford University Hospital / Stanford Health Care | Stanford, California, United States | — |
| Emory Clinic | Atlanta, Georgia, United States | — |
| Massachusetts General Hospital | Boston, Massachusetts, United States | — |
| Brigham and Womens Hospital | Boston, Massachusetts, United States | — |
| Lahey Hospital and Medical Center | Burlington, Massachusetts, United States | — |
| Michigan Medicine - Michigan Clinical Research Unit | Ann Arbor, Michigan, United States | — |
| Saint Luke's Hospital of Kansas City | Kansas City, Missouri, United States | — |
| Morristown Medical Center (Atlantic Health System) | Morristown, New Jersey, United States | — |
| North Shore University Hospital | Manhasset, New York, United States | — |
| NYU Langone Health Medical Center - HCM Program Office (Study open to existing NYU patients only) | New York, New York, United States | — |
| Sanger Heart and Vascular Institute | Charlotte, North Carolina, United States | — |
+ 9 more locations — full list on the registry record.
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06347159